TLP Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-249
Closed -$68K 150
2018
Q3
$68K Buy
+249
New +$64.6K 0.11% 109
2018
Q2
Sell
-908
Closed -$199K 409
2018
Q1
$199K Buy
+908
New +$213K 0.14% 270
2017
Q3
Sell
-1,333
Closed -$251K 588
2017
Q2
$251K Buy
+1,333
New +$240K 0.23% 123

Other funds holding ELV

TLP Group's ELV Position: Q4 2018 in Review

TLP Group sold out of Elevance Health (ELV) in Q4 2018, closing a stake of 249 shares — an estimated $68K sold.

TLP Group first reported a position in ELV in Q2 2017 and held it in 3 quarters. The position peaked at $251K in Q2 2017. 997 funds tracked by Wall St. Rank hold ELV as of Q4 2018.

  • TLP Group reported no remaining Elevance Health position as of Q4 2018 after selling out during the quarter.
  • TLP Group sold 249 Elevance Health shares in Q4 2018, an estimated $68K.
  • TLP Group first reported a position in Elevance Health in Q2 2017 and held it in 3 quarters.
  • TLP Group's Elevance Health position peaked at $251K in Q2 2017.
  • 997 funds tracked by Wall St. Rank held Elevance Health as of Q4 2018.

Based on TLP Group's 13F filing for Q4 2018, filed 14 Feb 2019.